Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Insmed Inc
0JAVCurrent price
67.22 USD
+5.18 USD (+8.35%)
Last closed
62 USD
Company
www.insmed.com
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
10 821 314 560 USD
Yield for 12 month
+252.47 %
1Y
3Y
5Y
10Y
15Y
0JAV
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
74.93 USDP/E ratio
–Dividend Yield
–Current Year
+305 208 000 USD
Last Year
+245 358 000 USD
Current Quarter
+75 500 000 USD
Last Quarter
+83 693 000 USD
Current Year
+239 635 000 USD
Last Year
+190 232 000 USD
Current Quarter
+56 780 000 USD
Last Quarter
+65 250 000 USD
Key Figures 0JAV
1 year
3 years
5 years
10 years
EBITDA
-671 894 976 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-31.79 %
PEG Ratio
–
Return On Equity TTM
-1453.41 %
Wall Street Target Price
74.93 USD
Revenue TTM
315 494 016 USD
Book Value
-3.13 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.8 %
Dividend Yield
–
Gross Profit TTM
190 232 000 USD
Earnings per share
-5.23 USD
Diluted Eps TTM
-5.23 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-236.74 %
Dividend Analytics 0JAV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0JAV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.03.2011
Dividend Date
–
Stock Valuation 0JAV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
14.6561
Price Sales TTM
13.2635
Enterprise Value EBITDA
-6.7757
Price Book MRQ
25.4507
Financials 0JAV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0JAV
For 52 weeks
19.74 USD
70.65 USD
50 Day MA
41.77 USD
Shares Short Prior Month
10 856 976
200 Day MA
30.62 USD
Short Ratio
2.14
Shares Short
11 568 176
Short Percent
7.19 %
BeatStart